title: Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.
abstract: OBJECTIVE
  To provide an update on the genes associated with Cushing's syndrome in children, as well as to familiarize the clinician with recent treatment guidelines and outcome data for children with Cushing's syndrome.
  
  
  RESULTS
  The list of genes associated with Cushing's syndrome continues to grow. In addition, treatment for childhood Cushing's syndrome is evolving. As long-term follow-up data on children becomes available, clinicians need to be aware of the issues that require attention.
  
  
  CONCLUSIONS
  Knowledge of the specific genetic causes of Cushing's syndrome has potential implications for treatment, surveillance, and counseling. Advances in surgical technique, radiation modalities, and medical therapies offer the potential for additional treatment options in Cushing's syndrome. Early identification and management of post-treatment morbidities in children treated for Cushing's syndrome is crucial in order to optimize care.
authors.affiliation: Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Maya
authors.initials: M
authors.lastname: Lodish
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D042241:Early Diagnosis; D005817:Genetic Counseling; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D017410:Practice Guidelines as Topic
chemical_list: D000893:Anti-Inflammatory Agents; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone